Identifying a
bona fide
population of cardiac stem cells (CSCs) is a critical step for developing cell-based therapies for heart failure patients. For more than a decade, c-kit, a receptor tyrosine kinase expressed in certain types of hematopoietic stem cells, has been recognized as a marker of resident CSCs in mammals. It was shown that c-kit
+
cells are multipotent, with differentiation potential to become cardiomyocytes, endothelial, and smooth muscle cells
in vitro
and after cardiac injury. Here, we provide new insights into the nature of cardiac resident c-kit
+
cells. By targeting the
c-kit
locus with several reporter genes in mice, we unexpectedly found that c-kit
+
cells rarely co-localizes with cardiac progenitor marker Nkx2.5 or myocardial marker cTnT. Instead, c-kit labels an endocardial population from embryonic stage to adulthood. After acute cardiac injury, the c-kit
+
cells still retain their endothelial identity and do not become cardiomyocytes. Our study supports the notion that cardiac c-kit
+
cells are in fact endothelial cells and not CSCs. This finding suggests an urgent need to re-evaluate the mechanisms by which c-kit
+
cells contribute to heart repair or regeneration given their endothelial identity.
Effects of Matrix Metalloproteinases on the Performance of Platelet Fibrin Gel Spiked With Cardiac Stem Cells in Heart Repair
